Official recall notice

FDA DrugClass IINotable

Levothyroxine Sodium Tablets Recall (Sep 2026)

Product: Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.

Recall date
2026-09-02
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Subpotent Drug

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Subpotent Drug

Affected products

Lot #: D2402337, Exp. Date 10/31/2026.

Verify with the official notice →
Share:

Related Recalls

2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-45
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451-
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for:
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457
ACCORD HEALTHCARE, INC.